340B stakeholders are responding to a long investigative article in Saturday’s New York Times that accuses a Catholic health system of exploiting the 340B discount program at the expense of one of its inner-city hospitals to enrich its other hospitals
…
Ryan White Clinics for 340B Access (RWC-340B), a national organization of 340B HIV/AIDS medical providers, has published a detailed rebuttal of several recently published articles criticizing the 340B program. RWC-340B accuses article authors—many of whom are supported by the drug
…
340B disproportionate share hospitals (DSH) in 2020 spent 2.2 times more on outpatient drugs per commercially insured patient than non-340B DSH hospitals and 2.6 times more than other types of 340B hospitals, a new drug industry-funded study shows.
The
Healthcare providers can suppress attacks on and build support for the 340B program by doing more to show the program helps vulnerable patients, the anesthesiologist who served as President Trump’s surgeon general said yesterday.
“We are fighting to deliver care
…
Top federal 340B program officials and the head of a 340B hospital group yesterday urged covered entity representatives attending a meeting near Washington, D.C., to focus on documenting and telling their 340B success stories.
The need to show that 340B
…
HIV/AIDS clinics and community health centers that participate in the 340B program yesterday announced the first 340B conference exclusively for grantee covered entities, Oct. 18-19 in Denver.
Ryan White Clinics for 340B Access (RWC-340B), National Association of Community Health Centers
…
It’s not just the drug industry stepping up its effort to influence the public and policymakers over the increasingly heated battle over the 340B program.
Groups that represent 340B hospitals and hospital pharmacists have launched a digital advertising campaign “to
…
Growth in 340B covered entities’ use of contract pharmacies to dispense 340B drugs, coupled with growth in pharmacy benefit managers’ control over these pharmacies, has given PBMs an outsized, profit-driven role in the 340B program that does not benefit patients,
…*Sign up for news summaries and alerts from 340B Report